AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Investigating the Effects of the Digital App Rheumabuddy4.1 in a Clinical RCT Set-up in Patients With Rheumatoid Arthritis

RecruitingNAAges 18 Years - 65 YearsAllHenning Bliddal
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Rheumatoid arthritis (RA) is one of the most frequently occurring autoimmune rheumatic diseases, affecting an estimated 1% of the global population. RA is a chronic inflammatory disease that leads to the development of synovial inflammation and effusion, ultimately followed by joint destruction and permanent disability. The substantial socioeconomic burden and the challenge of RA patients adhering to treatment is an important factor of this disease and its impact on both patients and society. An innovative approach is needed in order to find new ways to assist and truly empower patients to understand their disease, increase compliance and thereby increase quality of life. There is a discrepancy in the understanding of what's of importance when living a life with a chronic disease. The importance of patients' perspectives concerning disease- and treatment related impacts, is of crucial

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: An individual must meet all of the following criteria to be enrolled in the study: 1. Diagnosed with RA according to the EULAR \& American College of Rheumatology 2. PGA level \>= 40mm 3. Age โ‰ฅ 18 years and \< 65 years 4. Motivated for the intervention 5. Willing and able to understand and participate in the study 6. DAS28-CRP โ‰ค 3.2. 7. Ability to use the RB4.1 app Exclusion Criteria: An individual will be excluded from the study if she meets any of the following criteria: 1. Dementia or other linguistic/cognitive/physical deficiency that prevents participation 2. Vision impairment that prevents the use of the devices and computer 3. Change in DMARD (within 8 weeks) 4. Chronic widespread pain (fibromyalgia) based on patient anamnesis/medical record. 5. Acute infections based on patient anamnesis/medical record. 6. Severe asthma based on patient anamnesis/medical record. 7. Severe COPD based on patient anamnesis/medical record. 8. Instable heart disease based on patient anamnesis/medical record. 9. Intensive physiotherapy outside standard care based on patient anamnesis/medical record. 10. Electrostimulation based on patient anamnesis/medical record. 11. Motivation training based on patient anamnesis/medical record. 12. Smoking based on patient anamnesis/medical record. 13. Fever based on patient anamnesis/medical record. 14. If pain/fatigue are considered a side effect judged by the treating physician. 15. Other autoimmune diseases based on patient anamnesis/medical journal. 16. Mental diseases based on patient anamnesis/medical record. 17. All other non-pharmacological therapies that may impact the course of RA judged by the treating physician. 18. Any comorbid condition, that in the opinion of the investigator would interfere with the conduction of the trial or the interpretation of the study outcome. 19. Previous use of health apps related to the RA disease.
๐Ÿ’Š

What it tests

  • Digital app RB4.1
  • Control arm
๐Ÿ“

Where

1 site
The Parker Institute, Bispebjerg and Frederiksberg Hospital
Frederiksberg, Denmark
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy